stockportfolio.pro
TG Therapeutics, Inc. Total Debt 2011–2025
TG Therapeutics, Inc. (TGTX) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $245.65M | +0.5% |
| FY 2024 | $244.43M | +143.4% |
| FY 2023 | $100.40M | +41.1% |
| FY 2022 | $71.14M | +5.0% |
| FY 2021 | $67.76M | +126.7% |
| FY 2020 | $29.89M | +3.2% |
| FY 2019 | $28.97M | — |
| FY 2018 | $0 | — |
| FY 2017 | $0 | — |
| FY 2016 | $0 | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
Source: TG Therapeutics, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s total debt (short- plus long-term borrowings)?
TG Therapeutics, Inc. (TGTX) reported total debt (short- plus long-term borrowings) of $245.65M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.